The Tel Aviv, Israel-based company designed CGuard for the prevention of stroke. It utilizes the company’s MicroNet technology for strong acute results and durable, stroke-free, long-term outcomes.

InspireMD highlighted the importance of the transition to the new European Medical Device Regulations (EU MDR).

“We are very pleased to have now received formal recertification of our CE mark under MDR, allowing us to continue to work to make CGuard EPS the standard of care for carotid artery revascularization in our existing commercial territories while also advancing our new product pipeline using the pathway provided under MDR,” said CEO Marvin Slosman.